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Objective
The purpose of this study is to analyze colorectal cancer (CRC) screening rates post-enactment
of KRS 214.540 through 214.540. More specifically this study seeks to highlight the variation in
CRC screening rates post-policy vs. pre-policy among the target population: uninsured
individuals between the ages of 50 – 64.
Methods
Behavioral Risk Factor Surveillance System (BRFSS) was utilized to obtain individual-level data
regarding CRC screening in Kentucky from 2004-2012. Statistical Analysis System (SAS)
version 9.1 was utilized to compile data and the variables for home blood-stool and for
sigmoid/colonoscopy were combined into one variable to identify individuals who had received
any type of CRC screening from 2004-2012. The variables for year of screening, age, race,
education, income, health insurance, and access to care were utilized for the purposes of this.
Initial analysis of the data was conducted using basic descriptive statistics and Open Epi was
utilized to calculate screening rates and rate ratios with 95% confidence interval.
Results
Overall CRC screening rates have increased by 9.3% since the enactment of the policy. However
there has been no significant increase in CRC screening rates among those specifically targeted
by the policy; uninsured individuals between the ages of 50 – 64.
Conclusion
Results suggest that while overall CRC screening rates have increased in Kentucky since the
enactment of the policy, the target population of the policy has not seen a significant increase in
screening rates; suggesting that other factors besides the policy could be causing an increase in
CRC screening rates.
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Introduction
Colorectal Cancer (CRC) is defined as cancer that develops in the tissues of the large
intestine (colon) or the rectum. (1-3) CRC usually begins as a polyp, a growth on the inner lining
of the colon or rectum, which has the potential to gradually develop into cancer over a period of
10 to 20 years. (1-4) Persons who are at most risk of developing CRC include: individuals 50 and
older, males, African American’s, and individuals with personal or family history of CRC. (2)
Today, CRC is the third most commonly diagnosed cancer in both men and women and the third
leading cause of cancer death in the United States. (5) The American Cancer Society estimates
that in the United States approximately 132,700 individuals will be diagnosed with CRC and an
estimated 49,700 will die from this disease in 2015. (5)
One of the most effective ways of preventing CRC is through regular screening or
testing. (1-3, 6) Research shows that 50% of overall decline in incidence and 53% of decline in
mortality for CRC from 1975 to 2000 was attributable to screening. (7) Screening is both a
primary and secondary prevention measure, which aims to reduce mortality through a reduction
in incidence of CRC or through early detection and treatment of CRC. (1-4, 6) To this end,
screening can reduce the incidence of CRC through detection and removal of adenomatous
polyps. (1-4, 6) Additionally, screening can also reduce the mortality of CRC through the detection
of early-stage adenocarcinomas when treatment is more effective. (1-4) When CRC is detected at a
localized stage, when the invasive cancer has only penetrated the wall of the colon; the 5-year
survival rate is 90%. (4, 5) It is estimated that 9 out of 10 colorectal cancers today can be prevented
or cured through screening and regular checkups. (2, 3)
Due to the increasing body of evidence regarding the positive impact of CRC screening
on incidence and mortality rates, there has been a national effort to increase access and use of
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CRC screening. Several strategies have been used across the United States to reduce CRC
barriers, raise awareness, and educate the general population about the importance of screening.
(4)

These strategies have included screening campaigns, enactment of health insurance policies

that increase access to CRC screening tests, and creation of colon cancer prevention programs. (4)
Despite these efforts, as of 2012, only 65.1% of the US population ages 50 and older were up-todate with one of the CRC screening tests, while 27.7% of the population had never been
screened. (4, 8) Screening rates of CRC also varied greatly by states as the percentage of adults
who reported being current for CRC screening ranged from 55.7% in Arkansas to 76.3% in
Massachusetts. (8)
CRC has left a significant footprint on the health of individuals throughout the U.S.;
however, the burden of this disease has been especially significant in Kentucky. (9, 10) For the
years 2007 to 2011 combined, Kentucky had the highest CRC incidence rate in the nation and
the fourth highest mortality rate in the nation. (9, 10) Today CRC is the second most commonly
diagnosed cancer in both men and women and the second leading cause of cancer death in
Kentucky. (10) Due to its high burden of CRC, Kentucky is in a unique position to decrease both
incidence and mortality rates through the adoption of screening practices. However, the current
CRC screening rate of 62.9% is suboptimal as it ranks 33rd in the nation and is below the national
average of 65.1%.(4, 9, 10) Nonetheless, over the past decade Kentucky has made great strides
toward decreasing the incidence and mortality rate while simultaneously increasing CRC
screening rates. (10) From 2001 to 2011, the overall CRC incidence has decreased by 24% and the
overall CRC mortality rate has decreased by 23%, while the screening rate over this time period
has increased by over 47%. (10-12)
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The success Kentucky has achieved to date is has been in part due to a statewide effort
geared toward reducing the burden of CRC by addressing the gaps in CRC service and care.14
Approaches used toward achieving this goal include: data collection, implementation of
strategies to educate the public and health professionals about CRC screening, and the creation
of CRC policies that increase access to CRC screening and treatment.14 One great achievement
of the statewide effort to reduce the burden of CRC in Kentucky is the enactment of Kentucky
Revised Statutes 214.540 through 214.544, which are collectively referred to as the Colon
Cancer Screening Program.10, 14 These four statutes laid the foundation for the creation of a
colorectal cancer (CRC) screening program in the State of Kentucky. KRS 214.540 outlined the
purpose of the CRC screening program, which was to increase CRC screening rates, decrease
morbidity and mortality related to CRC, and decrease cost of treating CRC among citizens of
Kentucky. (10) KRS 214.542 outlined the eligibility criteria for the screening program, and stated
the program would provide screening to uninsured individuals who are age fifty to sixty-four and
other uninsured individuals determined to be at high risk for developing CRC. (10) KRS 214.544
created a CRC screening advisory committee and tasked the Kentucky Cancer Program with
establishing a CRC screening, education, and outreach program that focused on individuals who
lacked access to CRC screening. (10) In 2008 when the policy was first passed no funds were
appropriated for the creation and implementation of the CRC screening program, however DPH
moved forward with creating the program that focused on providing education and outreach
throughout Kentucky with the grants that totaled $68,000. (10) It was not until 2012 that
$1,000,000 was allocated to counties across the state to address CRC screening for the
uninsured. (10)
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There is no evidence of research that has been done to analyze the impact of the KRS
214.540 through 214.544 on CRC screening rates in the state of Kentucky. The purpose of this
study is to analyze CRC screening trends post-enactment of KRS 214.540 through 214.540.
More specifically this study seeks to highlight the variation in CRC screening rates among the
target population of this policy, which includes uninsured individuals who are age fifty to sixtyfour and other uninsured individuals determined to be at high risk for developing CRC. The
results of this study will assist in the evaluation of KRS 214.540 through 214.540 by determining
its impact on CRC screening rates and mortality rates and provide recommendations as to how
the policy can be amended to improve CRC outcomes in Kentucky.
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Literature Review
The following review of literature represents a summary of the key concepts and
relationships that are vital to understanding colorectal cancer and the prevention of colorectal
cancer. The literature in this review was found using a search strategy of PubMed, academic
search complete, and Google Scholar. The following key words and phrases were utilized for the
search: colorectal cancer, colorectal cancer epidemiology, colorectal cancer risk factors,
colorectal cancer screening, colorectal cancer screening tests, colonoscopies, fecal occult blood
test, cost-effectiveness of colorectal cancer screening, colorectal cancer prevention, colorectal
cancer policy, and colorectal cancer screening programs. Any relevant literature that was not
captured by the search strategy but referenced in the reviewed literature was also analyzed for
the purposes of this literature review.
The first portion of this literature review is focused on defining colorectal cancer,
providing the epidemiology of colorectal cancer in Kentucky and identifying the risk factor of
colorectal cancer that contribute to the development of this disease both in the United States and
in Kentucky. The second portion of the literature review focuses on colorectal cancer screening
in terms of what is colorectal cancer screening and its effectiveness, why colorectal cancer
screening is cost effective, the different colorectal screening exams that are available to the
general public, and colorectal cancer screening rates across the United States and in Kentucky.
The literature review concludes with a discussion on the different types of prevention strategies,
including policy change, that are currently being used to increase colorectal cancer screening
rates across the United States and in Kentucky.
Colorectal Cancer
Colorectal Cancer (CRC) is defined as cancer that develops in the tissues of the large
intestine (colon) or the rectum. (1-3) The colon and rectum are part of the gastrointestinal (GI)
6

system, which is responsible for the digestion of food for energy and absorption of fluid to form
solid waste that is passed out of the body. (1-3) CRC usually begins as a polyp, growth on the
inner lining of the colon or rectum, which has the potential to gradually develop into cancer over
a period of 10 to 20 years. (1-4) Most polyps are not cancerous but a specific type of polyp known
as adenomas have the potential to turn into malignant tumors. (1-3) Over 95% of colorectal
cancers are adenocarcinomas. (1,2) If a polyp turns into a malignant tumor, it can begin to grow
into the wall of the colon and rectum and eventually spread to other parts of the body. (1-3)
However, early detection and removal of precancerous polyps is a common mechanism by which
CRC can be prevented. (2)
Overview of Colorectal Cancer in Kentucky
Today, CRC is the third most commonly diagnosed cancer in both men and women and
the third leading cause of cancer death in the United States. (5) The American Cancer Society
estimates that in the United States approximately 132,700 individuals will be diagnosed with
CRC and an estimated 49,700 will die from this disease in 2015. (5) CRC poses a significant
health concern in the state of Kentucky due to the fact that both the incidence and mortality rates
of CRC are significantly higher in Kentucky then in the United States. (6,7) For the years 2001 to
2005 combined, that national age-adjusted CRC incidence and mortality rates were 49.2 per
100,000 persons and 18.8 per 100,000 persons respectively. (7) During that same time period the
Kentucky age-adjusted incidence and mortality rates were 59.3 per 100,000 person and 22.0 per
100,000 persons. (7) The incidence and mortality rates in Kentucky for those years were 20.5%
and 17.5% higher when compared to the national rate. (7)
More recently, the combined national age-adjusted CRC incidence rate for the years 2007
to 2011 was 43.3 per 100,000 persons compared to the Kentucky age-adjusted rate of 52.7 per
100,000 persons, which was highest in the nation. (6,8) Similarly, the national age-adjusted
7

mortality rate of CRC for the years 2007 to 2011 combined was 15.9 per 100,000 persons, while
the rate for Kentucky was the fourth highest in the nation at 18.9 per 100,000 persons. (6, 8) The
incidence and mortality rates in Kentucky for the years 2007 to 2011 were 21.7% and 18.9%
higher than the national rate. Based on this data, it is evident that both the US and Kentucky
incidence and mortality rates have been steadily declining but the rate of decline is much slower
in Kentucky compared to the United States. Thus, the gap between CRC incidence and mortality
rates in Kentucky and those for the United States has remained the same over time.
Today CRC is the second most commonly diagnosed cancer in both men and women and
the second leading cause of cancer death in Kentucky. (8) Current estimates show that It
approximately 2,090 Kentuckians will be diagnosed with CRC and 850 Kentuckians will die
from this disease in 2015. (5) However, as indicated previously, Kentucky has made tremendous
progress in reducing the overall burden of CRC. 2011 data shows that the combined age-adjusted
incidence and mortality rates of CRC in Kentucky are 48.9 per 100,000 persons and 17.9 per
100,000 persons, which is significantly lower than 2001 rates of 63.8 per 100,000 and 22.6 per
100,000 persons. (7, 8) Much of the decrease in CRC incidence and mortality rates in the United
States and in Kentucky has been attributed to identification and reduced exposure to modifiable
CRC risk factors, improvement and increase in early screening of CRC, and the improvement of
CRC treatment options for individuals. (4, 9)
Impact of CRC Risk Factors in Kentucky
While science has been unable to determine the exact cause of most CRC, researchers in
the United States have found several non-modifiable and modifiable risk factors increase the risk
of developing polyps or CRC. (1-3) Non-modifiable risk factors are factors that cannot be altered
thus making them hard to target through interventions. (1-3) Non-modifiable risk factors of CRC
include age, gender, race/ethnic background, and personal or family history. (1-2) Modifiable risk
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factors on the other hand are factors that can be altered and thus can be targeted through lifestyle
changes or interventions in order decrease the risk of developing CRC. (1-3) Modifiable risk
factors of CRC include physical inactivity, high consumption of red or processed meat, obesity,
moderate to heavy alcohol use, and smoking. (1-2)
Non-Modifiable Risk Factors
Age is a major non-modifiable risk factor for CRC. (1, 2, 4) CRC is most common among
individuals 50 and older as the risk of developing CRC increases with age. (1, 2, 4) Today 90% of
new cases and 93% of CRC deaths occur in people 50 and older. (4) Being male also increases the
risk of CRC across all age groups. (10) A 2009 study analyzing gender and its association with
CRC found that men were 1.83 times more likely to develop CRC compared to women. (10) This
positive association between gender and CRC was significant across all age groups from 40 to
older than 70 years. (10) Race/ethnicity is another risk factor that has shown to increase the risk of
CRC. (4, 11) CRC incidence and mortality rates are highest among African American men and
women and the lowest among Asian American/Pacific Islander men and women. (4, 11) Data
shows that incidence rates are 20% higher and mortality rates are approximately 45% higher in
African Americans than those in Caucasians. (4, 11) Two other non-modifiable risk factors that
impact CRC incidence and mortality rates include personal and or family history. Individuals
with a personal history of CRC, a history of adenomatous polyps, and who have chronic
inflammatory bowel disease have a higher risk of developing CRC. (1, 2, 4) Additionally,
individuals with a first-degree relative (parent, sibling, or offspring) who have had CRC are 2 to
3 times more likely to develop CRC than individuals with no family history of CRC. (4) About
20% of all CRC patients have a close relative who was diagnosed with the disease but a family
history of CRC is associated with better disease survival, which could be attributed to increased
awareness and earlier detection of CRC. (4, 12)
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The trends that are seen across the United States in non-modifiable risk factors of CRC
are reflected in Kentucky, but at much higher rate. The age-adjusted incidence rates and
mortality rates for men in Kentucky for years 2007-2011 were 62.4 per 100,000 persons and 22.6
per 100,000 persons respectively. (6, 8) This represents a 24.8% higher incidence and 18.3%
higher mortality rate than the national average for men. (6, 8) The incidence and mortality rates for
women in Kentucky are 25.0% and 28.8% lower than that of men in Kentucky, but both rates are
still approximately 19.0% higher than national rates for women. (6, 8) CRC incidence and
mortality rates in Kentucky also vary by race. (8) For years 2006-2010, African American’s in
Kentucky had an incidence rate of 61.9 per 100,000 persons and mortality rate of 25.3 per
100,000 person, which were significantly higher compared to their White counterparts who had
an incidence rate of 53.6 per 100,000 and mortality rate of 18.7 per 100,000. (8) The incidence
rates for African American’s (61.9 per 100,000) and Whites (53.6 per 100,000) in Kentucky are
also significantly higher compared to the national rates for African American’s (52.9 per
100,000) and Whites (43.7 per 100,000). (8) A similar trend is observed with the mortality rates,
as African American’s (25.3 per 100,000) and Whites (18.7 per 100,000) in Kentucky have a
significantly higher mortality rates compared African American’s (22.8 per 100,000) and Whites
(15.9 per 100,000) nationally. (8)
Modifiable Risk Factors
Physical Activity is one of the most consistently reported modifiable risk factor
associated with CRC. (1, 2, 4, 13) Studies consistently have found that physical activity has a
protective effect on CRC. (13) For example, a recent study that analyzed the association between
physical activity and risk of CRC found that the risk of CRC was 25% lower among individual
who were most physically active versus the individuals who were least physically activity. (14) It
is estimated that 30 to 60 minutes of moderate to vigorous physical activity per day is needed to
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protect against colon cancer. (13) Physical activity may protect against CRC through its role in
“energy balance, hormone metabolism, and insulin regulation.” (13) Other factors that have a
protective effect on CRC include consumption of dietary fiber, dairy, fruit, and vegetables. (15-17)
However, high consumption of red and processed meats has shown to increase the risk for CRC.
(18)

There are several theories as to why consumption of red and processed meats increases the

risk of CRC. One of the more prominent theories is that nitrites or nitrates that are added to meat
for preservation are converted by our body into nitrosamines or other N-nitroso-compounds,
which are potentially cancer causing chemicals. (18) Being overweight/obese has shown to
increase the risk of CRC. (1, 2, 4, 19, 20) A 2008 study looking body mass index and incidence of
CRC found that for both men and women, a higher BMI was strongly associated with increased
risk of CRC but the association was slightly weaker in women. (20) Research has also shown that
individuals who are obese are 1.2 times more likely to develop CRC than individuals who are not
obese. (4) The current hypothesis is that obesity increases risk of CRC due to the high levels of
insulin or insulin related growth factors found in obese individuals. (19) Two other factors that
increase the risk of CRC are smoking and alcohol. (1, 2, 4, 21, 22) Research shows that current
smokers are 1.2 more likely to develop CRC then individuals who have never smoked, while
heavy alcohol drinkers are 1.6 times more likely to develop CRC then nondrinkers. (4, 22, 23)
The decrease in incidence and mortality rate of CRC over time, both in Kentucky and
across the United States, can be attributed to the identification and the reduction of exposure to
the modifiable CRC risk factors listed above. (4, 9) A 2009 investigation of CRC in the United
States reported that changes in risk factors accounted for 50% of the overall decline in incidence
rates and 35% of the decline in mortality rates from 1975 to 2000. (24) However, Kentucky CRC
incidence and mortality rates are still significantly higher than the national rates due to the fact
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that the population of Kentucky has a high prevalence of modifiable factors that increase CRC
risk. (6, 7, 25) Today, Kentucky ranks among the top ten states with the highest rates of physical
inactivity (42nd), obesity (46th), and smoking (49th), as well as ranking as one of the worst states
in terms of consumption of fruits (45th) and vegetables (46th). (26) Additionally, CRC incidence
rates, mortality rates, as well as the prevalence rates of CRC risk factors vary significantly
among the different geographical areas within Kentucky. (25) One area of specific interest is
Eastern Kentucky, which includes the Appalachian region of Kentucky. (25) Counties in Eastern
Kentucky and those that are a part of the Appalachian region have a higher prevalence of
modifiable risk factors (smoking and obesity) and lower prevalence of protective factors
(consumption of fruit and vegetables and daily exercise) and consequently they also have one of
the highest incidence and mortality rates in the state. (8, 25) Incidence rates (56.7 per 100,000) and
mortality rates (21.0 per 100,000) in the Appalachian region of Kentucky are significantly higher
compared to the incidence rates (52.9 per 100,000) and mortality rates (18.4 per 100,000) in
Non-Appalachian regions of Kentucky. (8) In order for Kentucky to significantly reduce the
burden CRC within the state, Kentucky needs to reduce the prevalence of modifiable risk factors,
which increase the risk of developing CRC.
Colorectal Cancer Screening
Colorectal Cancer Screening and its Impact
One of the most effective ways of preventing CRC is through regular screening or
testing. (1-3, 9, 27-31) Research shows that 50% of the overall decline in incidence and 53% of
decline in mortality for CRC from 1975 to 2000 is attributable to screening. (24) Furthermore,
research shows that mortality rates have been decreasing by approximately 3% over the past
decade due to an increase in access and use of CRC screening tools. (4, 32) CRC screening is both
a primary and secondary prevention measure, which aims to reduce mortality through a reduction
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in incidence of CRC and through detection and treatment of early-stage CRC. (1-4, 9) CRC
screening serves as a primary prevention measure due to the fact that screening can reduce the
incidence of CRC through detection and removal of adenomatous polyps. (1-4, 9) Since
adenomatous polyps can take as many as 10 to 20 years to develop in to CRC, regular screening
has the ability to prevent many cases of CRC altogether through the finding and removal of
polyps before they turn cancerous. (1-4) CRC screening also serves as secondary prevention
measure due to the fact that screening reduces the mortality of CRC through the detection of
early-stage adenocarcinomas when treatment is more effective. (1-4) The relative 5 and 10 year
survival rate for individuals with CRC is 65% and 58% respectively. (5) However, when CRC is
detected at a localized stage, when the invasive cancer has only penetrated the wall of the colon,
the 5-year survival rate is 90%. (4, 5) If the cancer has spread regionally to the lymph nodes, the 5year survival rate decreases to 71% and if the cancer has spread to distant organs, the 5-year
survival rate decreases even further to 13%. (4, 5) Thus, CRC screening is an extremely effective
and cost-efficient method of decreasing the burden of CRC. (1, 3, 9)
Cost Effectiveness of Colon Cancer Screening
In addition to decreasing mortality rates by finding CRC in its pre-cancerous stage,
screening can also significantly reduce the financial burden associated with treating invasive
cancer. (1-4) Annual expenditure for treatment of CRC was estimated to be more than $14 billion
in 2010 and was projected to increase to over $17 billion in 2020. (33, 34) The 24.9% increase in
costs was attributed to increase in the aging population, improved survival, and increased costs
of care. (33, 34) Recent estimates show that CRC treatment in the first year after diagnosis costs an
average of $51,000 with continuing care costs of $3,500 per year. (34) Cost of screening on the
other hand is significantly less than that of the cost of treating cancer and when the screening
identifies CRC in its early stages, the cost of treatment is often much less expensive. (33) 2007
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estimates show that the median price over a 10-year interval for CRC screening tests such as
colonoscopy and fecal occult blood test (FOBT) were $432 and $45 per procedure respectively.
(33)

Furthermore, economic models have found that when comparing the cost of CRC diagnosed

at the local stage, the lifetime treatment cost is $7,000 more for regional stage and $16,000 for
distant stage CRC. (35) A systematic review of cost-effectiveness analysis for CRC screening
methods found that screening would result in an average cost-effectiveness ratio ranging from
$10,000 to $25,000 per year of life saved. (36)
Colorectal Cancer Screening Options
Today there is a range of options for CRC screening, with current tests falling into two
general categories: stool test and structural exams. (1-4, 9) Stool tests are low-priced, non-invasive
tests, which are best suited for the detection of cancer. (1-4, 9) They are unlikely to detect the
presence of polyps and require testing of the stool for signs of cancer. (1-4) the most commonly
used stool test is the fecal occult blood test (FOBT). (9, 37) The FOBT is designed to detect the
presence of occult blood in the stool, which is a possible symptom of early cancer. (1-4, 9) Today
there are two types of FOBT available: guaiac-based FOBT, which detect blood in the colon or
rectum from any source, and immunochemical FOBT, which detect only human blood from the
large bowel. (4, 9) Patients, who have a positive FOBT, are referred for a colonoscopy to rule out
the presence of polyps of cancer. (1, 4, 9) A recent clinical trial conducted in Minnesota found that
the regular use of FBOT reduced CRC mortality by 33% after 18 years of follow up, suggesting
that FBOT is an effective screening tool with the ability to decrease the mortality of CRC. (927)
The U.S. Preventive Services Task Force (USPSTF) recommends that adults age 50 to 75 should
undergo annual screening with the fecal occult blood test. (38)
Structural exams, unlike stool tests, have the ability to detect both cancer and
precancerous growth. (1-4, 9) Structural exams are invasive tests that look at the structure of the
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colon and rectum using a scope or x-ray to find polyps and or abnormal areas. (1-4, 9) The most
commonly used structural exam is a colonoscopy, where the physician utilizes a colonoscope to
exam the rectum and colon for the presence of polyps or cancer. (1, 4, 9, 37) A physician also has the
ability to remove most polyps and some cancers during the procedure. (4) A 2012 study
examining the impact of colonoscopic polyectomy, found that removal of polyps during a
colonoscopy resulted in a 53% reduction in mortality which suggest that colonoscopies are an
effective screening tool and intervention for CRC. (9, 30) According to USPSTF, adults age 50 to
75 should be screened for CRC via a colonoscopy every 10 years. (38)
Screening Rates for Colorectal Cancer in Kentucky
Despite the availability of a range of CRC screening options and studies having shown
that CRC screening is an economical and effective method of decreasing the burden of CRC, a
significant portion of the US population has never been screened. (4) As of 2012, only 65.1% of
the US population ages 50 and older were up-to-date with one of the CRC screening tests
recommended by the USPSTF, while 27.7% of the population had never been screened. (4, 37)
Studies analyzing CRC screening rates, have found that barriers, both perceived and encountered
by patients, are a major reason for the low screening rates. (4, 39) Common barriers for CRC
include: cost associated with screening, lack of health insurance, inadequate communication by
health care providers, failure of physicians to recommend screening, lack of information, lack of
symptoms, and personal barriers to screening such as fear, embarrassment. (4, 39)
However over the past decade, the United States has made significant progress in increasing
the screening rates from 33.9% in 2000 to 65.1% in 2012. (37, 40) Much of the increase in CRC
screening rates has been attributed to an increased use of colonoscopy as a screening tool. (4, 37, 40)
Colonoscopy use has almost tripled from 19% in 2000 to 55% in 2010. (4, 37, 40) Among adults
50 and older, 61.7% reported having been screened with a colonoscopy in 2012. (37) Yet there is
15

still more work to be done. (37, 40) Today CRC screening rates still remain low among adults
younger than 65, among men, and among those who are non-white, have less than a college
education, have a low household income, lack health insurance, and lack a regular health care
provider. (4, 37) Screening rates of CRC also vary greatly by states. (4) In 2012, the percentage of
adults who reported being current for USPSTF recommended screening ranged from 55.7% in
Arkansas to 76.3% in Massachusetts. (37)
More specifically, the CRC screening rate for Kentucky in 2012 was 62.9%, which was
slightly below the national rate of 65.1%. (37) Many of the barriers that led to low screening rates
across the United States are also present in Kentucky. (8) A 2011 study analyzing the barriers to
CRC screening in Kentucky concluded that the top five barriers for Kentuckians were: failure of
physician to recommend screening, lack of symptoms and no family history of cancer, lack of
desire to be screened, cost, and lack of health insurance. (41) However similar to the United
States, Kentucky has made significant progress over the past decade in increasing the CRC
screening rates within the state. (8) The screening rates in Kentucky have nearly doubled since
1999, when only 34.7% of Kentuckians had been screened, to 62.9% of Kentuckians being
screened in 2012. (8, 37) Even though Kentucky has seen a massive spike in CRC screening, there
is still a lot of work to be done if Kentucky is to reduce the overall burden of CRC within the
state. (8) There are still slightly more than a third of Kentuckians who meet the age criteria but
have not been screened. (8) Furthermore, similar to the United States, Kentuckians who are males,
non-white, non-college graduates, low income, and who lack health insurance have significantly
lower screening rates than their counterparts. (8)
Prevention of Colorectal Cancer in Kentucky
Due to the increasing body of evidence regarding the positive impact of CRC screening
on incidence and mortality rates, there has been a national effort to increase access and use of
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CRC screening. Several strategies have been used across the United States to increase screening
rates through reduction of CRC barriers, raising awareness, and educating the general population
about CRC and the importance of screening. (4) Three strategies that are currently being used
across the United States and in Kentucky include screening campaigns, enactment and or
modification of health insurance policies that increase access to CRC screening tests, and
creation of colon cancer prevention programs. (4) The guide to community preventive services,
which utilizes systematic reviews to identify program and policy interventions that have proven
to be effective, identified screening campaigns as an effective intervention for increasing
screening rates. (44) Unfortunately, the guide did not analyze the effectiveness of mandating
insurance providers to cover CRC screening and or creating CRC prevention programs. (44)
Screening Campaigns
CRC screening campaigns are one of the many strategies that are currently being used to
raise awareness and educate the general population about CRC and the importance of CRC
screening. (42) Screen for a Life: National Colorectal Cancer Action Campaign is one of the
longest running multimedia screening campaigns and is aimed at increasing CRC screening
among people age 50 and older. (43) The initiative, which was started in 1999 by the CDC, aims
to educate and inform individual’s age 50 and older about the importance of regular CRC
screening through the use of television, radio, public service announcements, and celebrity
endorsements. (43) According to the guide to community preventative service, there is insufficient
evidence to determine if mass media campaigns such as Screen for a Life are effective or not. (44)
However a study done in 2003 analyzing the impact of Katie Couric’s televised CRC awareness
campaign found that there was a temporary increase in colonoscopy use after the campaign,
which suggests that celebrity endorsements have a significant impact on screening rates. (45)
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Other screening campaigns that have proven to work are small media campaigns with a target
audience especially when the campaigns were combined with another strategy. (44)
Since 2009 the Kentucky Department for Public Health in combination with the
Kentucky Cancer Consortium, University of Kentucky, and University of Louisville has made a
concerted effort to raise awareness and educate Kentuckians about the benefits of CRC
screening. (8) In 2009, the Targeted Colon Cancer Outreach Program, which was a product of
KRS 214.540 through KRS 214.540, was established in each of Kentucky’s 15 Area
Development Districts, with the goal of providing education and outreach to individuals who
lack access to colon cancer screening. (8) Since its inception the program has distributed 36,400
posters/bookmarks, 32,700 promotional pieces, and 30,700 education materials to individuals
across the state. (8) Furthermore, the program has also led a small media campaign that included a
combination of television and radio shows, public service announcements, and
newsletter/newspaper articles. (8) It is estimated that 91,000 people were reached through the
small media campaign. The program also surveyed Kentuckians to determine the impact of the
education and outreach campaign. (9) The results from the survey showed that out of the 852
respondents, 95% reported the program helped increase their knowledge about CRC and 64%
reported that they planned to talk with their health care provider about screening. (8)
Increased access to Health Care
One of the major barriers to CRC screening is a lack of health insurance. (4) Studies have
shown that mandating insurance providers cover CRC screening can increase rates of screening.
(46-51)

For example, in 2001, Medicare expanded coverage to cover colonoscopies for average-

risk Medicare beneficiaries, which resulted in higher rates of colonoscopy utilization after the
expansion. (46-48) Another study conducted by the American Cancer Society, analyzed colon
cancer screening rates in states that had passed laws requiring insurers to cover CRC screening
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versus states that had not passed such laws. (49) The result of this study showed that screening
rates in the states with coverage laws had risen 40% faster than rates in states without such laws.
(49)

As demonstrated by the studies listed above and other similar studies, CRC screening rates

can be improved significantly by mandating insurers cover CRC screening. (46-51) To this end
there has been an increased emphasis over the past several years to create and enact policies that
would make CRC screening insurance coverage mandatory across the United States.
Over the past decade, 29 states including Kentucky have passed laws that require the
mandatory coverage of CRC screening by all health insurance policies written in the state. (53)
More recently, in 2009, the federal government passed the Affordable Care Act (ACA), which
expanded Medicaid coverage to low-income adults and mandated coverage of preventive
services with an “A” or “B” recommendation from the USPSTF. (54) With CRC screening, the
ACA required all health insurance plans that started on or after September 23, 2010 to cover
CRC screening tests, which received an “A” rating from USPSTF. (54) Based on past studies it is
possible that the rates of CRC screening should see a dramatic increased due to the combination
of state and federal mandates requiring the coverage of CRC screening by health plans and the
increased number of individuals with insurance. (46-51)
However, one of the big issues with the new ACA regulation and CRC is that Medicare
patients could still be exposed to screening costs because the ACA makes a distinction between a
screening colonoscopy and a diagnostic colonoscopy. (1, 55) A screening colonoscopy is defined
as a screening test that patients undergo when there is no signs or symptoms of CRC. (1, 55) A
diagnostic colonoscopy on the other had is defined as a test performed due to an abnormal
finding, signs, or symptoms of CRC. (1, 55) Therefore if a polyp or abnormal growth is removed
during a screening colonoscopy or if a patient undergoes a colonoscopy after receiving a positive
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bloodstool test, the procedure is deemed a diagnostic in nature. (1, 55) If the procedure were
deemed diagnostic, the patient would be charged for the colonoscopy if it was not covered by the
patient’s insurance policy or if the patient had a copay or deductible. (1, 55) This loophole in the
ACA has turned into a major barrier for CRC screening. (55, 56) In 2013, Representative Charles
Dent introduced the Removing Barriers to Colorectal Cancer Screening Act, which would
eliminate all costs associated with the removal of a polyp during a colonoscopy and thus
ensuring that unexpected copays do not hinder patients from getting screened. (56) Unfortunately
the bill has not been passed and thus cost barriers to CRC screening still exist due to this
loophole in the ACA. (55, 56)
Kentucky is one of the 29 states to have enacted a law that requires all insurance
providers cover CRC screening. (53) Kentucky Revised Statute 304.17A-257 requires that any
health benefit plan issued or renewed on or after January 1, 2009 to cover all CRC examinations
and laboratory tests as specified in current American Cancer Society guidelines. (57) According to
the statue the individuals that shall be covered include, individuals 50 years of age or older; or
less than 50 years of age but at high risk for colorectal cancer. (57) In addition, the statute also
mandates that CRC coverage “shall not be subject to separate deductible or separate coinsurance
but may be subject to the same deductible or coinsurance established for other laboratory test
under the health benefit plan.” (57) Similar to the ACA, one of the issues with this statute is that
patients can still be exposed to costs associated with screening becoming diagnostic if polyps are
removed during a regular colonoscopy due to the test being classified as a diagnostic test rather
than a screening test. (58) In order to eliminate this cost, Representative Tom Birch, D-Louisville,
filled a bill that would amend the statute to require health benefits plans to cover all costs
regardless of the procedures being performed during the screening encounter. (58) The bill, which
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was singed and implemented on March 23, 2015, will eliminate all cost sharing for CRC
screening in Kentucky and thus increase access to CRC screening for all Kentuckians. (58)
Colon Cancer Screening Programs
The purpose of a screening program is to test a large number of individuals with a simple
and inexpensive screening test that identifies individuals with increased risk for cancer or those
who are in its early stages. (59) One of the first steps when starting a screening program is to
determine the type of test that will be used. (60) For CRC there are two main choices: a one-step
screen or a two-step screen. (60) One-step screening involves the use of a definitive test such as a
colonoscopy, while two-step screening involves the utilization of a simple test such a FOBT first
and those with a positive result are then offered a definitive test like the colonoscopy. (60) Studies
have found that both the one-step and two-step screening programs are effective in decreasing
the burden of CRC. (60) However two-step screening programs have shown to be more costeffective because the tests utilized in the first step cost significantly less than the tests used in the
second step and since the first step eliminates majority of the population that is asymptomatic,
only a fraction of the population is actually screened using the second step. (60)
Today there are both national and state level CRC screening programs, which aim to
reduce the burden of CRC. CDC’s Colorectal Cancer Control Program (CRCCP) is the largest
national CRC screening program that aims to improve screening rates across the United States.
(61)

The program, which was established in 2009, provides funding to 29 states and 4 tribal

organizations to increase CRC screening rates to 80% in those areas by 2014. (61) The program
utilizes evidence-based strategies and in some cases provides CRC screening and follow-up care
to individuals aged 50-64 years who are underinsured or uninsured. (61) Since the creation of the
program, CRCCP has provided more than 34,000 CRC screening exams. (61) A 2013 study
comparing states who received CDC funding to establish their own CRC screening programs
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versus states who did not receive CDC funding, found that states with funding were significantly
more likely to provide free screening to the underinsured and uninsured. (62)
One of the states that was not funded by the CDC, but still has its own CRC screening
program, is the state of Kentucky. (8, 61) Kentucky created its CRC screening program in 2008
with the enactment of Kentucky Revised Statues (KRS) 214.540 through 214.544. (63) KRS
214.540 gave Kentucky Department of Public Health (DPH) the authority to create a Colon
Cancer Screening Program (KCCSP) with the purpose of: increasing colon cancer screening,
reducing morbidity and mortality from colon cancer, and reducing the cost of treating colon
cancer. (63) KRS 214.542 outlined who was eligible for the colon cancer-screening program, who
would provide the services, how the program would be funded, and mandated that DPH establish
a data collection system for CRC. (63) According to KRS 214.542, the program was to “provide
colon cancer screening for uninsured individuals who are age fifty to sixty-four and other
uninsured individuals determined to be at high risk for developing colon cancer.” (63) The policy
did not state why this specific age group was chosen as the target group of the CRC screening
program. Additionally, KRS 214.544 created the colon cancer screening advisory committee
whose purpose is to “provide recommendations for the overall implementation and conduct of
the colon cancer screening program” and it also mandated that the Kentucky Cancer Program
establish the Targeted Colon Cancer Outreach Program, which was discussed above. (63)
Unfortunately when the Kentucky Revised Statutes were enacted in 2008, no funding was
allocated for the creation and implementation of KCCSP. (64) However, the lack of funding did
not stop DPH from establishing the program. (64) However due to the fact that DPH did not have
any funding to provide screening for the uninsured, the program served as more of a prevention
program, which focused on education, outreach, and data collection, rather than a true screening
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program. (64) DPH utilized several grants that totaled $68,000 to provide education and outreach
to Kentuckians from 2008 to 2010. (10) It was not until 2010 that KCCSP was funded and even
than the funding was limited to $200,000 and was divided among four Kentucky counties: Floyd,
Letcher, Martin, and Pike. (65) Pike and Floyd counties were first to be funded because these
counties already had a self-funded CRC screening program. (65) Then in 2012, an additional
$170,000 was allocated to Floyd, Knott, and Pike counties to help provide screening in those
counties. (8) Also in 2012, Governor Beshear budgeted $500,000 in fiscal year 2013 and
$500,000 in fiscal year 2014 to expand colon cancer screening for uninsured Kentuckians. (8) The
Kentucky Cancer Foundation will match the funding. (8) However as mentioned previously, due
to the fact that very limited funding was allocated to KCCSP from 2008 to 2012, the program
dedicated majority of its efforts to providing education and raising awareness regarding CRC
screening to Kentuckians who were uninsured or lacked access to CRC screening. (8)
Literature Review Summary
A review of literature regarding CRC indicates that CRC is a highly preventable disease
that plagues our nation today. More specifically the burden of disease is extremely high in
Kentucky. Research has shown that prevention through screening is the most effective of
reducing the burden of colorectal cancer, yet a significant portion of our population has never
been screened. Due to the increasing body of evidence demonstrating the effectiveness of CRC
screening, a number of strategies have been used across the United States to increase the rates of
CRC screening. More specifically, Kentucky created a colon cancer screening in 2008 with the
purpose of increasing screening rates, providing education and outreach, and to provide
screening for the uninsured. Unfortunately, no research has been done to analyze the impact of
the colon cancer-screening program on CRC screening rates in Kentucky since its creation in
2008 or the subsequent modification and funding of the program.
23

Methods
The purpose of this capstone was to analyze colorectal cancer (CRC) screening rates
post-enactment of Kentucky Revised Statute 214.540, which established the Kentucky Colon
Cancer Screening Program (KCCSP). More specifically this study seeks to highlight the
variation in CRC screening rates among the population targeted by the policy. To this end, a prepost analysis of CRC screening rates, was conducted using statewide data from 2004-2012 to
identify variation in screening rates. Additionally the study focused on the uninsured individuals
who are age fifty to sixty-four in Kentucky. This study was exempt from IRB review since it
used publicly available BRFSS survey data containing de-identified respondent records
(Appendix 1).
Data Source
CDC Behavioral Risk Factor Surveillance System (BRFSS) was utilized to obtain
individual-level data regarding CRC screening in Kentucky for the years 2004-2012. (66) BRFSS
is an on-going, state-based, random digit telephone survey that collects state-level prevalence
data on health-related risk behaviors, chronic health conditions, and use of preventive services.
(66, 67)

The survey, which is administered by state health departments with the assistance from

CDC, randomly selects adults who live in a household with a landline telephone. (66, 67) The
survey is comprised of standard core questions (included every year), rotating core questions
(included biannually), optional modules, and state-added questions. (66, 67) CRC screening
questions are a part of the rotating core questions and thus appear on the BRFSS survey every 2
years (in even-numbered years). (66, 67) For the purposes of this study, BRFSS survey data for the
years 2004, 2006, 2008, 2010, and 2012 were used.
The state of Kentucky utilizes a “disproportionate stratified sampling” technique to
obtain a random sample of Kentucky telephone numbers that can be surveyed. (68) A pre24

calculated weighting variable that is provided by the CDC is used to weigh the data to account
for over/under sampling of certain subgroups and allows for the survey data to be representative
of the Kentucky population. (68) Weighting is most often used to adjust the race category due to
the fact that the Kentucky population is predominately white and the low number of non-white
populations tends to make the data for this specific population statistically unstable. (66, 8) The
following survey items were analyzed in the present study: year of survey completion, health
insurance coverage, lack of financial access to services (measured by inability to see a physician
because of the cost of the visit), age, race, education, income, gender, and if the respondent had
ever had either a blood stool home test or a sigmoidoscopy/colonoscopy.
Sample Population
Analyses were limited to individuals in Kentucky aged 50 and older. A total of 40,194
individuals in this age group completed the BRFSS survey from 2004 to 2012. Of these 16,071
(46.07%) were excluded from the study due to either missing data or a lack of response to the
CRC screening questions. The remaining 24,123 individuals served as the sample population for
this study.
Procedure
Data from 2004 to 2012 was compiled into one data set using the Statistical Analysis
System (SAS) version 9.1. The variables for home bloodstool and those who had either a
sigmoid or colonoscopy were combined into one variable to identify individuals who had
received any type of CRC screening for the years 2004 – 2012.
The variables for year of screening, age, race, education and income were recoded for the
purposes of this study. Variable for year of screening was recoded to indicate when the
individual responded to the survey, either pre-policy or post-policy. Individuals who responded
in 2004, 2006, or 2008 were coded as pre-policy and individuals who responded in 2010 or 2012
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were coded as post policy. For the variable age, the respondents were broken down into three
categories of 50 – 64, 65 – 75, and 75+. For the variable race, the respondents were broken down
into three categories of white, African American, and other. For variable education the
respondents were broken down into four categories of less than 11 years of education, 12 years
of education, 13 to 15 years of education or 16 + years of education. Variable income was
broken down into 4 categories of less than $25,000, $25,000 to $49,999, $50,000 to $74,999, and
$75,000 or more.
Initial analysis of the data was conducted using basic descriptive statistics. Ultimately a
pre-post analysis of CRC screening rates was conducted using a rate ratio. The pre policy and
post policy screening rates were calculated using the formula:

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑣𝑖𝑑𝑢𝑎𝑙𝑠 𝑠𝑐𝑟𝑒𝑒𝑛𝑒𝑑
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑅𝑒𝑠𝑝𝑜𝑛𝑑𝑒𝑛𝑡𝑠

. The

pre policy and post policy screening rates were then compared using a rate ratio with a 95%
𝑆𝑐𝑟𝑒𝑒𝑛𝑖𝑛𝑔 𝑅𝑎𝑡𝑒 𝑃𝑜𝑠𝑡 𝑃𝑜𝑙𝑖𝑐𝑦

confidence interval. The formula: 𝑆𝑐𝑟𝑒𝑒𝑛𝑖𝑛𝑔 𝑅𝑎𝑡𝑒 𝑃𝑟𝑒 𝑃𝑜𝑙𝑖𝑐𝑦 was utilized to calculate the rate ratio.
Open Epi was utilized to calculate both screening rates and rate ratios in this study.
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Results
Overall Population Characteristics
The total population who responded to colorectal cancer (CRC) questions on the
Behavioral Risk Factor Surveillance System (BRFSS) survey from 2004 to 2012, as shown in
table 1, consisted of 24,123 Kentuckians, between the ages of 50 – 99. Of the 24,123
respondents, 92.9% were Caucasians, 68.3% were females and 52.8% were between the ages of
50 – 64. More than half of the respondents reported having less than 12 years of education
(56.35%) and earning less than $50,000 (59.7%); however the overwhelming majority of
participants had some form of health insurance (91.3%). Majority of respondents also reported
having been screened for CRC at some point in time (69.7%).
Variation in the Screened and Never Screened Population
Of the respondents who had been screened for CRC (Table 1), a greater proportion of
females (N = 11701, 71.04%) reported having been screened compared to males (N = 5120,
66.92%). Proportion of individuals who reported having been screened increased with age,
education, and income level. Individuals who lacked health insurance (N = 916, 44.44%) and
who lacked access to healthcare (N=1690, 58.62%) were less likely to have been screened for
CRC compared to individuals who had health insurance (N = 15877, 72.11%) and had access to
healthcare (N=15091, 71.27%). Minimal variation was observed in the proportion of racial
subgroups that reported CRC screening. Roughly seventy-percent of both whites (N = 15651,
69.85%) and African Americans (N = 875, 70.51%) reported being screened for CRC. A greater
proportion of individuals reported having been screened in the post policy years (N = 8975,
72.78%) compared to pre policy years (N = 7846, 66.54%).
Of the sample that reported never having been screened for CRC, a greater proportion of
males (N = 2531, 33.08%) reported never having been screened compared to females (N = 4771,
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28.96 %). Furthermore, the proportion of individuals who reported never having been screened
for CRC decreased with age, education, and income. Individuals who lacked health insurance (N
= 1145, 55.56%) and or who lacked access to healthcare (N = 1193, 41.38%) were more likely to
never have been screened for CRC compared to individuals who did have health insurance (N =
6141, 27.89%) and access to healthcare (N = 6083, 28.73%). Both white (N = 6757, 30.15%) and
African American (N = 366 or 29.49%) individuals were equally likely to report not having been
screened for CRC.
Pre Policy vs. Post Policy Variation in Overall Population
Out of the 16,821 individuals who reported being screened for CRC, 7846 (46.64%) were
screened before KRS 214.540 through 214.540 was implemented and 8975 (53.36%) were
screened after the statute was implemented (Table 3). Both the pre-policy and post-policy
groups had similar characteristics as the majority of the screened sample consisted of individuals
who were females, Caucasian, between the ages of 50 – 64, who had less than 12 years of
education, and earned less than $50,000 annually. The majority of respondents in both groups
did have health insurance and access to care.
A rate comparison between the pre-policy and the post-policy group revealed that overall
screening rates had increased significantly by 9.3% after the policy had been implemented (Table
4). More specifically there was a significant increase in screening among both males and
females, among individuals of all age groups, among Caucasians, among individuals with either
12 or 13 to 15 years of education, and among individuals who earned less than $50,000 annually.
The groups that did not see a significant increase were African Americans, individuals with 11 or
fewer and 16 or more years of education, individuals with no health insurance, and individuals
who lacked access to care.
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Pre Policy vs. Post Policy Variation in Target Population (Table 5 and Table 6)
A total of 8262 respondents between the ages of 50 - 64 reported having been screened
for CRC. Of those 8262 respondents, 3915 (47.39%) were screened pre-policy and 4347
(52.61%) were screen post-policy (Table 5). In both groups majority of screened individuals
included females, Caucasians, individuals with less than 12 years of education, and individuals
who earned less than $50,000 annually. Majority of respondents reported having health insurance
and access to care.
Rate comparison between the pre-policy and the post-policy group revealed that there
was a significant increase (8.3%) in screening rates post-policy (Table 6). The individuals that
saw a significant increase in screening rates post-policy included females (9.6%), Caucasians
(8.7%), individuals with health insurance (9.0%), individuals with health care access (8.6%), and
individuals who earned less than $25,000 annually (12.5%).
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Discussion
In 2008, the Kentucky Legislature passed Kentucky Revised Statutes (KRS) 214.540
through 214.544. (8, 63) These four statutes laid the foundation for the creation of a colorectal
cancer (CRC) screening program in the State of Kentucky. KRS 214.540 outlined the purpose of
the CRC screening program, which was to increase CRC screening rates, decrease morbidity and
mortality related to CRC, and decrease cost of treating CRC among citizens of Kentucky. (63)
KRS 214.542 outlined the eligibility criteria for the screening program, and stated the program
would provide screening to uninsured individuals who are age fifty to sixty-four and other
uninsured individuals determined to be at high risk for developing CRC. (63) KRS 214.544
created a CRC screening advisory committee and tasked the Kentucky Cancer Program with
establishing a CRC screening, education, and outreach program that focused on individuals who
lacked access to CRC screening. (63) While the policy itself did not specify what should be
included in the education and outreach program, the Department for Public Health took several
steps to increase awareness of CRC in Kentucky. For example the education and outreach
program; distributed public awareness and educational materials such as posters, bookmarks, and
church bulletins, it conducted CRC education presentations for health care providers and
community organizations, it utilized regional and small media campaigns raise awareness. (63)
However, the provisions outlined above were limited to the amount of appropriations that
were provided to the Department for Public Health for the CRC screening program. (63)
Unfortunately the program was unable to secure funding from Kentucky Legislature until 2012
and thus from 2008 to 2012 the program served mainly as a prevention program that provided
the education and outreach mentioned previously to Kentuckians who were uninsured and who
lacked access to CRC screening. (8) The purpose of this study was to determine if there had been
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a significant increase in CRC screening rates from 2008, when the Colon Cancer Screening
Program was established, till 2012 when the program was funded. More specifically the study
aimed to determine if there had been a significant increase in CRC screening rates among the
target population of the CRC screening program, which included uninsured individuals between
the ages of 50 -64 and other uninsured individuals determined to be at high risk for developing
colon cancer. (63)
While the policy did not specify the reason for uninsured individuals between the ages of
50 – 64 being the target population of the policy, previous research demonstrates that early
detection of CRC increases long-term survival. (1) Thus by targeting individuals between the ages
of 50 – 64, many cases of CRC can be prevented all together or can be discovered and treated at
an early stage when the 5-year survival rate is 90%. (1) Research also demonstrates that
individuals between the ages of 50 – 64 and individuals who are uninsured tend to have the
lower screening rates compared to their older counterparts. (4, 69) A 2011 study, analyzing
screening rates from 2002 to 2008 discovered that the proportion of individuals who reported
having been screened was greater among individuals older than 65 compared to individuals
between the ages of 50 – 64. (69) Finally, it is important to note that individuals over the age of 65
are automatically eligible for Medicare and thus they have greater access to CRC screening.
Individuals between the ages of 50 – 64 on the other hand have private insurance, Medicaid if
they are eligible due to falling below the poverty line, and or they have no insurance at all. What
this means is that individuals between the ages of 50 – 64 are more like to be uninsured and
research shows us that individuals who have health insurance are more likely to be screened
compared to individuals with no health insurance. (69) The combination of increased survival

31

through early detection, the need to increase low screening rates, and the greater likelihood of 50
– 64 year olds being uninsured, makes these individuals great target of the policy.
Observations from the present study indicate CRC screening has significantly improved
since the enactment of KRS 214.540 through 214.544. Analysis of individuals who were
screened based on their gender, age, race, education, income, health insurance, and health care
access revealed an increase in screening rates for all subgroups post enactment of the policy
(Table 3). Although the methodology in this study did not allow for direct analysis of the policies
impact on CRC screening rates, the observed trend is reflective of the policies intended aim of
increased CRC screening in Kentucky.
Analysis of Kentucky individuals between the ages of 50 – 64 revealed an overall
increase of 8.3% in screening rates since the enactment of KRS 214.540. Furthermore, analysis
based on gender, race, education, health insurance, access to care, and income for individuals
between the ages of 50 - 64 revealed that CRC screening rates had increased across all
subgroups. However further analysis of these individuals revealed there was no significant
increase among individuals who traditionally have lower rates of CRC screening. For example,
previous research has demonstrated that minority individuals, individuals with low educational
attainment or low income, and individuals with no health insurance or access to care tend to have
lower screening rates for CRC because of the barriers faced by these individuals. (4, 37) Some of
the barriers faced by these individuals include cost associated with screening, lack of providers,
lack of information, lack of awareness, and personal barriers such as fear or embarrassment. (4, 39)
The results of this study show that there was no statistically significant increase among the
minority individuals, individuals with less than a college education, individuals with no health
insurance or access to care. This finding suggests that the policy, which was created to target

32

uninsured individuals between the ages of 50 – 64 or other uninsured individuals who had a high
risk of CRC, might not have had an impact on the target population. There are several reasons
that the policy might not have had an impact on the target population such as: lack of funding for
the CRC screening program prevented the Department for Public Health from providing CRC
screening services to the target population, the policy did not address other issues related to
CRC, or the education and outreach efforts of the policy did not reach the target population.
One of the more interesting findings of this study was that individuals who earned less
than $25,000 annually saw statistically significant increase in post policy screening rates. As
mentioned previously, research shows that individuals with low income tend to have lower
screening rates, yet the opposite was found in this study. (4, 39) There are a combination of factors
that could have contributed to this increase among low-income individuals. First and foremost
research shows that individuals of low-income status have lower rates of CRC screening due to
lack of health insurance, lack of access to care, and lack of awareness about CRC. (4, 39) Second,
the economic recession of 2008 led to high unemployment rates and falling income levels and as
a result, many families had to turn to Medicaid for health insurance. (70) It is estimated that 11.5
million people have been enrolled in Medicaid programs since 2007. (70) Consequently, Medicaid
enrollment was up around the same time as the CRC screening program was created in
Kentucky. This combination of newly acquired health insurance, improved access to care, and
being educated about CRC screening could explain the increase in screening rates for individuals
who earn less than $25,000 annually post-enactment of KRS 214.540.
The results of this study reveal that there has been a significant increase in overall
screening rates since the enactment of KRS 214.540 through 214.544. Furthermore, there was no
significant increase in screening rates among the target population of this policy; uninsured
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individuals between the ages of 50 – 64 and uninsured individuals who were considered at high
risk of CRC. The lack of significant increase could be attributed to the policy requiring the CRC
screening programs to provide actual screens for uninsured individuals between the ages of 50 –
64. However due to a lack of funding, the CRC screening program has only been able to provide
education and outreach to Kentuckians, not actual screening services. This would mean that
individuals without health insurance would still face barriers such as cost and lack of access to
care, thus result in no significant increase in screening rates post-enactment of policy.
The results of this study reveal several steps, which can and should be taken to aid in
increasing the screening rates of CRC in the state of Kentucky. First and foremost, previous
research and the results of this study show that the two factors that significantly increase CRC
screening rates are health insurance and access to care. (46, 51) The lack of health insurance issue
was partially addressed by the enactment of the Affordable Care Act (ACA) in 2010. (54) The
ACA, which expanded Medicaid eligibility and offers costs assistance through health insurance
marketplaces, allowing thousands of Kentuckians who were uninsured prior to the ACA to get
health insurance. (54, 55) Due to the increase in individuals with health insurance, there should be a
rise in screening rates for CRC however this increase will not be seen till after 2013 when open
enrollment in the Health Insurance Marketplace will begin.
The ACA also mandated that insurance companies provide preventative services with an
“A” or “B” recommendation from the United States Preventive Services Task Force (USPSTF)
with no-copays or deductibles. (54, 55) Since CRC screening is a preventative measure, it is
covered entirely by new insurance plans. (54, 55) In theory, this new measure should help eliminate
barriers of cost as well as some barriers of access to CRC screening. However, new research has
shown that there is a loophole to the ACA mandate requiring insurance companies to completely
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cover preventative services when it comes to CRC screening. (55) If an individual goes in for a
screening colonoscopy and a polyp is discovered and subsequently removed, the procedure turns
from preventative to diagnostic care, thus the patient is then charged for the procedure. (55) This
loophole, which presents a major barrier to CRC screening, was addressed on March 23rd 2015
when Governor Beshear signed a bill that defined polyp removal as being an integral part of the
screening process and thus should be classified as preventative procedure rather than diagnostic
procedure. (58) The combination of increasing health insurance coverage, eliminating cost
sharing, and thus consequently increasing access to care should increase CRC screening rates.
Providing free screening to uninsured is one way to increase CRC screening rates in
Kentucky. Research shows that for uninsured individuals cost of screening and access to
screening services are major barriers. (4, 39) Providing free screening to the uninsured would
eliminate one of the biggest barriers to CRC screening. Unfortunately, when the CRC screening
program was first established no funding was allocated to provide actually screening services. As
a result, the program served more as a prevention program providing education and outreach to
Kentuckians, than a complete screening program. In 2012, however, Governor Steve Beshear
secured funding for the CRC screening program, which will now allow the program to provide
free CRC screening to Kentucky residents who meet the eligibility requirements. (8) To be
eligible for the free screening the individuals must be between the ages of 50 – 64 (African
Americans age 45-64) or qualify with certain high risk conditions/factors; a United States citizen
or qualified alien; a legal resident of Kentucky; uninsured; and their income must be at or below
250% of the federal poverty level. (8)
Limitations
There were several limitations to take into account when interpreting the results of this
study. One of the biggest limitations of this study was the BRFSS data that was utilized for
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analysis. BRFSS is a randomized telephone survey that collects self-reported data, which limits
the reliability and validity of the self-reported behaviors due to recall bias, over-reporting, underreporting, and the lack of the ability to validate the data using medical records. Second, CRC
screening rates that were calculated for the purposes of this study could have been
underestimated or overestimated because BRFSS provides only frequency data and does not
provide data on whether the test was done for screening or diagnosis purposes. Third, the
response rates for the BRFSS survey is usually low and a weighting procedure would have to be
used to account for the non-responses. Also, in 2011, the BRFSS survey was changed to allow
for cellular telephones, which resulted in changes to weighting procedure and thus data collected
prior to 2011 cannot be compared to data collected after 2011. Finally, the purpose of this study
was to identify variation in screening rates since the enactment of KRS 214.540 through 214.544
and not to quantify the impact of the policy. Consequently, this study can only conclude that
there was an increase in screening rates since the enactment of KRS 214.540 through 214.544,
however how much of that increase is attributable to actual policy cannot be determined based
on the methodology used and results obtained in this study.
Conclusion
In summary, overall CRC screening rates have significantly increased since the
enactment of KRS 214.540 through 214.544. However several subgroups such as minorities,
individuals with low educational attainment, individuals who lack health insurance, and
individuals who lack access to care saw no significant increases in CRC screening rates postenactment of the policy. This is consistent with national trends for these subgroups. This study
was the first step in determining the variation in screening rates since the enactment of KRS
214.540 through 214.544. Future studies should concentrate on attempting to determine the how
much of the increase in CRC screening is actually attributable to KRS 214.540 through 214.544.
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Table 1: Demographics of BRFSS Respondents to Colorectal Screening Question for Years 2004, 2006,
2008, 2010, & 2012
Variable

Screened
n

Total
Gender
Male
Female
Age (years)
50-64
65-75
75+
Unreported
Race
White
African American
Other
Unreported
Education (Years)
11 or Fewer
12
13 to 15
16 or More
Unreported
Health Insurance
Yes
No
Unreported
Lack of Healthcare Access
Yes
No
Unreported
Income
Less than $25,000
$25,000 - $49,999
$50,000 - $74,999
$75,000 or more
Unreported
Years
Pre Policy (2004, 2006, 2008)
Post Policy (2010, 2012)

(%)

Never Screened
n

(%)

Total Sample
n

(%)

16821

(69.73%)

7302

(30.27%)

24123

(100.00%)

5120
11701

(66.92%)
(71.04%)

2531
4771

(33.08%)
(28.96%)

7651
16472

(31.72%)
(68.28%)

8262
5629
2817
113

(64.85%)
(76.63%)
(73.69%)
(52.80%)

4478
1717
1006
101

(35.15%)
(23.37%)
(26.31%)
(47.20%)

12740
7346
3823
214

(52.81%)
(30.45%)
(15.85%)
(0.89%)

15651
875
210
85

(69.85%)
(70.51%)
(61.22%)
(64.89%)

6757
366
133
46

(30.15%)
(29.49%)
(38.78%)
(35.11%)

22408
1241
343
131

(92.89%)
(5.14%)
(1.42%)
(0.54%)

2716
6202
3992
3876
35

(59.71%)
(68.58%)
(72.06%)
(78.57%)
(60.34%)

1833
2841
1548
1057
23

(40.29%)
(31.42%)
(27.94%)
(21.43%)
(39.66%)

4549
9043
5540
4933
58

(18.86%)
(37.49%)
(22.97%)
(20.45%)
(0.24%)

15877
916
28

(72.11%)
(44.44%)
(63.64%)

6141
1145
16

(27.89%)
(55.56%)
(36.36%)

22018
2061
44

(91.27%)
(8.54%)
(0.18%)

1690
15091
40

(58.62%)
(71.27%)
(60.61%)

1193
6083
26

(41.38%)
(28.73%)
(39.39%)

2883
21174
66

(11.95%)
(87.78%)
(0.27%)

5521
4205
1924
2293
2878

(64.61%)
(71.77%)
(73.60%)
(76.46%)
(70.09%)

3024
1654
690
706
1228

(35.39%)
(28.23%)
(26.40%)
(23.54%)
(29.91%)

8545
5859
2614
2999
4106

(35.42%)
(24.29%)
(10.84%)
(12.43%)
(17.02%)

7846
8975

(66.54%)
(72.78%)

3946
3356

(33.46%)
(27.22%)

11792
12331

(48.88%)
(51.12%)
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Table 2: Characteristics of BRFSS Respondents who were Screened for Pre Policy and Post Policy Years (N =
24,123)
Variable

Screened Pre Policy

Total
Respondents
Pre Policy

Column
%

n

n

Total

Row (%)

Screened Post Policy

Total
Respondents
Post Policy

Column
%

n

n

Row (%)

7846

(100%)

(66.54%)

11792

8975

(100%)

(72.78%)

12331

Male

2372

(30.23%)

(63.92%)

3711

2748

(30.62%)

(69.75%)

3940

Female

5474

(69.77%)

(67.74%)

8081

6227

(69.38%)

(74.21%)

8391

50-64

3915

(49.90%)

(62.24%)

6290

4347

(48.43%)

(67.40%)

6450

65-75

2607

(33.23%)

(72.84%)

3579

3022

(33.67%)

(80.22%)

3767

75+

1297

(16.53%)

(70.26%)

1846

1520

(16.94%)

(76.88%)

1977

27

(0.34%)

(35.06%)

77

86

(0.96%)

(62.77%)

137

7497

(95.55%)

(66.72%)

11236

8154

(90.85%)

(72.99%)

11172

225

(2.87%)

(63.56%)

354

650

(7.24%)

(73.28%)

887

Other

91

(1.16%)

(61.07%)

149

119

(1.33%)

(61.34%)

194

Unreported

33

(0.42%)

(62.26%)

53

52

(0.58%)

(66.67%)

78

11 or Fewer

1511

(19.26%)

(57.89%)

2610

1205

(13.43%)

(62.15%)

1939

12

2892

(36.86%)

(65.50%)

4415

3310

(36.88%)

(71.52%)

4628

13 to 15

1762

(22.46%)

(69.32%)

2542

2230

(24.85%)

(74.38%)

2998

16 or More

1667

(21.25%)

(75.84%)

2198

2209

(24.61%)

(80.77%)

2735

Unreported

14

(0.18%)

(51.85%)

27

21

(0.23%)

(67.74%)

31

Yes

7388

(94.16%)

(68.78%)

10741

8489

(94.58%)

(75.28%)

11277

No

448

(5.71%)

(43.37%)

1033

468

(5.21%)

(45.53%)

1028

10

(0.13%)

(55.56%)

18

18

(0.20%)

(69.23%)

26

Yes

816

(10.40%)

(56.59%)

1442

874

(9.74%)

(60.65%)

1441

No

7017

(89.43%)

(67.97%)

10324

8074

(89.96%)

(74.41%)

10850

13

(0.17%)

(50.00%)

26

27

(0.30%)

(67.50%)

40

Less than $25,000

2569

(32.74%)

(60.89%)

4219

2952

(32.89%)

(68.24%)

4326

$25,000 - $49,999

1933

(24.64%)

(68.50%)

2822

2272

(25.31%)

(74.81%)

3037

$50,000 - $74,999

820

(10.45%)

(71.37%)

1149

1104

(12.30%)

(75.36%)

1465

968

(12.34%)

(75.21%)

1287

1325

(14.76%)

(77.39%)

1712

1556

(19.83%)

(67.21%)

2315

1322

(14.73%)

(73.81%)

1791

Gender

Age (years)

Unreported
Race
White
African American

Education (Years)

Health Insurance

Unreported
Lack of Healthcare Access

Unreported
Income

$75,000 or more
Unreported
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Table 3: Rates of Being Screened Pre Policy vs. Post Policy
Rate of Being
Screened Pre
Policy

Rate of Being
Screened Post
Policy

Per 1,000

Per 1,000

Total

665.4

Gender
*Male
*Female

Rate Ratio
(Post/Pre)

95% CI

727.8

1.094

1.061 - 1.128

639.2

697.5

1.091

1.033 - 1.153

677.4

742.1

1.096

1.056 - 1.136

Age (years)
*50-64
*65-75
*75+

622.4
728.4
702.6

674.0
802.2
768.8

1.083
1.101
1.094

1.037 - 1.131
1.045 - 1.161
1.016 - 1.178

Race
*White
African American
Other

667.2
635.6
610.7

729.9
732.8
613.4

1.094
1.153
1.004

1.060 - 1.129
0.991 - 1.342
0.765 - 1.320

Education (Years)
11 or Fewer
*12
*13 to 15
16 or More

578.9
655.0
693.2
758.4

621.5
715.2
743.8
807.7

1.073

0.995 - 1.158

1.092
1.073
1.065

1.039 - 1.148
1.008 - 1.142
0.999 - 1.135

Health Insurance
*Yes
No

687.8
433.7

752.8
455.3

1.094
1.050

1.061 - 1.129
0.922 - 1.195

Lack of Healthcare Access
Yes
*No

565.9
679.7

606.5
744.1

1.072

0.974 - 1.179

1.095

1.060 - 1.130

Income
*Less than $25,000
*$25,000 - $49,999
$50,000 - $74,999
$75,000 or more

608.9
685.0
713.7
752.1

682.4
748.1
753.6
773.9

1.121
1.092
1.056
1.029

1.063 - 1.182
1.028 - 1.160
0.965 - 1.156
0.947 - 1.118

Variable

* Significant Difference Post Policy compared to Pre Policy – 95% CI
49

Table 4: Characteristics of Respondents age 50 - 64 who were Screened for Pre Policy and Post Policy
Years (N = 12,740)
Variable

Screened Pre Policy

n
Total

(%)

Total
Respondents Pre
Policy

n

Screened Post
Policy

n

(%)

Total
Respondents
Post Policy

n

3915

(62.24%)

6290

4347

(67.40%)

6450

Male

1231

(59.07%)

2084

1392

(62.53%)

2226

Female

2684

(63.81%)

4206

2955

(69.96%)

4224

3723

(62.31%)

5975

3928

(67.70%)

5802

123

(60.89%)

202

338

(67.60%)

500

Other

56

(62.22%)

90

62

(54.39%)

114

Unreported

13

(56.52%)

23

19

(55.88%)

34

551

(52.48%)

1050

398

(54.75%)

727

1403

(59.78%)

2347

1529

(63.76%)

2398

13 to 15

973

(64.35%)

1512

1207

(69.37%)

1740

16 or More

985

(71.74%)

1373

1209

(76.57%)

1579

Unreported

3

(37.50%)

8

4

(66.67%)

6

Yes

3527

(65.41%)

5392

3912

(71.27%)

5489

No

382

(42.97%)

889

428

(45.01%)

951

6

(66.67%)

9

7

(70.00%)

10

Yes

572

(54.37%)

1052

624

(57.41%)

1087

No

3340

(63.90%)

5227

3710

(69.41%)

5345

3

(27.27%)

11

13

(72.22%)

18

Less than $25,000

1055

(54.33%)

1942

1200

(61.13%)

1963

$25,000 - $49,999

1021

(62.52%)

1633

1053

(66.31%)

1588

$50,000 - $74,999

557

(67.27%)

828

689

(70.96%)

971

$75,000 or more

730

(72.56%)

1006

939

(73.88%)

1271

Unreported

552

(62.66%)

881

466

(70.93%)

657

Gender

Race
White
African American

Education (Years)
11 or Fewer
12

Health Insurance

Unreported
Healthcare Access

Unreported
Income
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Table 5: Rates of Being Screened Pre Policy vs. Post Policy for Respondents ages 50 -64 who were Screened

Rate of Being
Screened Pre
Policy

Rate of Being
Screened Post
Policy

Per 1,000

Per 1,000

622.4

Male
*Female

Rate Ratio
(Post/Pre)

95% CI

674.0

1.083

1.037 - 1.131

590.7

625.3

1.059

0.981 - 1.143

638.1

699.6

1.096

1.040 - 1.155

*White

623.1

677.0

1.087

1.039 - 1.136

African American

608.9

676.0

1.110

0.903 - 1.365

Other

622.2

543.9

0.874

0.609 - 1.254

11 or Fewer

524.8

547.5

1.043

0.917 - 1.187

12

597.8

637.6

1.067

0.992 - 1.147

13 to 15

643.5

693.7

1.078

0.991 - 1.173

16 or More

717.4

765.7

1.067

0.981 - 1.161

*Yes

654.1

712.7

1.090

1.041 - 1.140

No

429.7

450.1

1.047

0.912 - 1.202

Yes

543.7

574.1

1.056

0.943 - 1.183

*No

639.0

694.1

1.086

1.037 - 1.138

*Less than $25,000

543.3

611.3

1.125

1.036 - 1.222

$25,000 - $49,999

625.2

663.1

1.061

0.973 - 1.156

$50,000 - $74,999

672.7

709.6

1.055

0.943 - 1.179

$75,000 or more

725.6

738.8

1.018

0.924 - 1.121

Variable

Total

Gender

Race

Education (Years)

Health Insurance

Lack of Healthcare Access

Income

* Significant Difference Post Policy compared to Pre Policy – 95% CI 
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